FDA Drug Application (084303) for ORPHENADRINE CITRATE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number084303
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameORPHENADRINE CITRATE
Active IngredientORPHENADRINE CITRATE

Active IngredientCount
List of drugs with Active Ingredient ORPHENADRINE CITRATE9


Back to FDA Applications sponsored by WATSON LABS